We describe 36 patients with splenic marginal zone lymphoma (SMZL) with transformation
(SMZL‐T), including 15 from a series of 84 patients with SMZL diagnosed at the Hospital …

In a series of 48 patients with splenic marginal zone lymphoma (SMZL) with circulating
villous lymphocytes, we describe the clinical and laboratory features of nine cases that …

Abstract The Integruppo Italiano Linfomi (IIL) carried out a study to assess the outcomes of
splenic marginal zone lymphoma and to identify prognostic factors in 309 patients. The 5 …

Splenic marginal zone lymphoma (SMZL) is a low grade B-cell lymphoma usually
characterized by an indolent clinical course and long survival (median 10 years)[1–3] …

Splenic marginal zone lymphoma (SMZL) is an indolent B cell malignancy usually involving
spleen, bone marrow and blood. The disease presents as an incidental finding or with …

Splenic marginal zone lymphoma (SMZL) is an indolent lymphoproliferative disease
accounting for approximately 1% of all lymphomas. SMZL presents with marked …

Since the initial description of splenic marginal zone lymphoma (SMZL) in 1992, an
increasing number of publications have dealt with multiple aspects of SMZL diagnosis …

Splenic marginal zone lymphoma (SMZL) is considered to be an indolent extranodal B-cell
lymphoma. Despite its low aggressivity, histologic progression has been described in …

Splenic marginal zone lymphoma (SMZL) is an indolent small B-cell lymphoma involving the
spleen and bone marrow characterized by a micronodular tumoral infiltration that replaces …

Splenic marginal zone lymphoma (SMZL) is a recently described and distinctive type of
splenic lymphoma and is characterized by an indolent clinical course. By analyzing a large …